Bio-Rad Stock Climbs Following the Launch of Four ddPCR PlatformsZacks Investment Research • 07/14/25
Bio-Rad Expands Droplet Digital PCR Offering Through Strategic Acquisition and Platform RolloutBusiness Wire • 07/07/25
Bio-Rad's Management to Host Investor Meetings During Jefferies Global Healthcare ConferenceBusiness Wire • 05/29/25
Investing in Bio-Rad (BIO)? Don't Miss Assessing Its International Revenue TrendsZacks Investment Research • 05/13/25
Bio-Rad's Management to Participate in Fireside Chat During 2025 RBC Capital Markets Global Healthcare ConferenceBusiness Wire • 05/12/25
BIO Beats on Q1 Earnings, Lowers '25 View, Stock Up in AftermarketZacks Investment Research • 05/02/25
Analysts Estimate Bio-Rad Laboratories (BIO) to Report a Decline in Earnings: What to Look Out forZacks Investment Research • 04/24/25
BIO Q4 Earnings and Revenues Miss Estimates, Stock Down AftermarketZacks Investment Research • 02/14/25
Bio-Rad Laboratories (BIO) Misses Q4 Earnings and Revenue EstimatesZacks Investment Research • 02/13/25
Earnings Preview: Bio-Rad Laboratories (BIO) Q4 Earnings Expected to DeclineZacks Investment Research • 02/06/25
Has BioRad Laboratories (BIO) Outpaced Other Medical Stocks This Year?Zacks Investment Research • 02/04/25
Bio-Rad to Report Fourth Quarter and Full Year 2024 Financial Results on Thursday, February 13, 2025Business Wire • 01/27/25
Geneoscopy Closes $105M in Series C Funding Round to Power Next-Generation of Gastrointestinal Diagnostic TestsBusiness Wire • 01/08/25